• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲创伤后大出血及凝血功能障碍管理指南:第五版。

The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.

机构信息

Institute of Anaesthesiology, University of Zurich and University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.

Department of Trauma and Orthopaedic Surgery, Cologne-Merheim Medical Centre (CMMC), University of Witten/Herdecke, Ostmerheimer Strasse 200, D-51109, Cologne, Germany.

出版信息

Crit Care. 2019 Mar 27;23(1):98. doi: 10.1186/s13054-019-2347-3.

DOI:10.1186/s13054-019-2347-3
PMID:30917843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6436241/
Abstract

BACKGROUND

Severe traumatic injury continues to present challenges to healthcare systems around the world, and post-traumatic bleeding remains a leading cause of potentially preventable death among injured patients. Now in its fifth edition, this document aims to provide guidance on the management of major bleeding and coagulopathy following traumatic injury and encourages adaptation of the guiding principles described here to individual institutional circumstances and resources.

METHODS

The pan-European, multidisciplinary Task Force for Advanced Bleeding Care in Trauma was founded in 2004, and the current author group included representatives of six relevant European professional societies. The group applied a structured, evidence-based consensus approach to address scientific queries that served as the basis for each recommendation and supporting rationale. Expert opinion and current clinical practice were also considered, particularly in areas in which randomised clinical trials have not or cannot be performed. Existing recommendations were re-examined and revised based on scientific evidence that has emerged since the previous edition and observed shifts in clinical practice. New recommendations were formulated to reflect current clinical concerns and areas in which new research data have been generated.

RESULTS

Advances in our understanding of the pathophysiology of post-traumatic coagulopathy have supported improved management strategies, including evidence that early, individualised goal-directed treatment improves the outcome of severely injured patients. The overall organisation of the current guideline has been designed to reflect the clinical decision-making process along the patient pathway in an approximate temporal sequence. Recommendations are grouped behind the rationale for key decision points, which are patient- or problem-oriented rather than related to specific treatment modalities. While these recommendations provide guidance for the diagnosis and treatment of major bleeding and coagulopathy, emerging evidence supports the author group's belief that the greatest outcome improvement can be achieved through education and the establishment of and adherence to local clinical management algorithms.

CONCLUSIONS

A multidisciplinary approach and adherence to evidence-based guidance are key to improving patient outcomes. If incorporated into local practice, these clinical practice guidelines have the potential to ensure a uniform standard of care across Europe and beyond and better outcomes for the severely bleeding trauma patient.

摘要

背景

严重创伤性损伤继续给全球医疗体系带来挑战,创伤后出血仍然是受伤患者中潜在可预防死亡的主要原因。本文为第五版,旨在为创伤后大出血和凝血病的管理提供指导,并鼓励根据机构情况和资源对本文中描述的指导原则进行调整。

方法

2004 年成立了泛欧多学科创伤高级出血处理工作组,现任作者组包括六个相关欧洲专业学会的代表。该小组采用结构化的循证共识方法解决科学问题,这些问题是制定每条建议及其支持依据的基础。还考虑了专家意见和当前的临床实践,特别是在没有或无法进行随机临床试验的领域。根据上一版以来出现的科学证据和临床实践的变化,重新审查和修订了现有建议。制定新的建议,以反映当前的临床关注点和新的研究数据产生的领域。

结果

对创伤后凝血病病理生理学的认识进展支持了改进的管理策略,包括早期个体化目标导向治疗改善严重受伤患者结局的证据。当前指南的总体组织旨在反映患者路径上的临床决策过程,大致按时间顺序排列。建议分组基于关键决策点的理由,这些决策点是面向患者或问题的,而不是与特定治疗方式相关。虽然这些建议为大出血和凝血病的诊断和治疗提供了指导,但新出现的证据支持作者组的信念,即通过教育和建立并坚持当地临床管理算法,可以实现最大的结果改善。

结论

多学科方法和循证指导是改善患者结局的关键。如果纳入当地实践,这些临床实践指南有可能确保欧洲乃至全球的护理标准统一,并改善严重出血创伤患者的结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/136f/6436241/3e6f44b21fc0/13054_2019_2347_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/136f/6436241/a66dbb108d12/13054_2019_2347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/136f/6436241/3e6f44b21fc0/13054_2019_2347_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/136f/6436241/a66dbb108d12/13054_2019_2347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/136f/6436241/3e6f44b21fc0/13054_2019_2347_Fig2a_HTML.jpg

相似文献

1
The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.欧洲创伤后大出血及凝血功能障碍管理指南:第五版。
Crit Care. 2019 Mar 27;23(1):98. doi: 10.1186/s13054-019-2347-3.
2
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition.《欧洲创伤后大出血和凝血功能障碍管理指南:第四版》
Crit Care. 2016 Apr 12;20:100. doi: 10.1186/s13054-016-1265-x.
3
The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition.《欧洲创伤后大出血及凝血功能障碍管理指南》第六版
Crit Care. 2023 Mar 1;27(1):80. doi: 10.1186/s13054-023-04327-7.
4
Management of bleeding and coagulopathy following major trauma: an updated European guideline.重大创伤后出血与凝血功能障碍的管理:欧洲最新指南
Crit Care. 2013 Apr 19;17(2):R76. doi: 10.1186/cc12685.
5
Management of bleeding following major trauma: an updated European guideline.严重创伤后出血的处理:欧洲最新指南。
Crit Care. 2010;14(2):R52. doi: 10.1186/cc8943. Epub 2010 Apr 6.
6
Current strategies for hemostatic control in acute trauma hemorrhage and trauma-induced coagulopathy.急性创伤性出血和创伤诱导性凝血病的止血控制策略。
Expert Rev Hematol. 2018 Dec;11(12):987-995. doi: 10.1080/17474086.2018.1548929. Epub 2018 Nov 27.
7
iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial.iTACTIC——实施创伤性凝血病纠正治疗算法:一项多中心随机对照试验的研究方案
Trials. 2017 Oct 18;18(1):486. doi: 10.1186/s13063-017-2224-9.
8
Guidelines for the Management of a Pregnant Trauma Patient.妊娠创伤患者管理指南
J Obstet Gynaecol Can. 2015 Jun;37(6):553-74. doi: 10.1016/s1701-2163(15)30232-2.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
Guidelines in trauma-related bleeding and coagulopathy: an update.创伤相关出血及凝血障碍指南:更新版。
Curr Opin Anaesthesiol. 2024 Apr 1;37(2):110-116. doi: 10.1097/ACO.0000000000001346. Epub 2024 Jan 22.

引用本文的文献

1
Trauma-induced dysfibrinogenemia: the von Clauss assay does not accurately measure fibrinogen levels after injury.创伤性异常纤维蛋白原血症:冯·克劳斯氏测定法不能准确测量损伤后的纤维蛋白原水平。
Blood Vessel Thromb Hemost. 2024 Jul 16;1(3):100017. doi: 10.1016/j.bvth.2024.100017. eCollection 2024 Sep.
2
Predicting postoperative trauma-induced coagulopathy in patients with severe injuries by machine learning.通过机器学习预测重伤患者术后创伤性凝血病
Sci Rep. 2025 Jul 25;15(1):27072. doi: 10.1038/s41598-025-13283-x.
3
Pre-hospital assessment of trauma associated severe hemorrhage (phTASH) - analysis of TraumaRegister DGU data from 2015-2021.

本文引用的文献

1
The S100A10 Pathway Mediates an Occult Hyperfibrinolytic Subtype in Trauma Patients.S100A10 通路介导创伤患者隐匿性高纤维蛋白溶解亚型。
Ann Surg. 2019 Jun;269(6):1184-1191. doi: 10.1097/SLA.0000000000002733.
2
Current strategies for hemostatic control in acute trauma hemorrhage and trauma-induced coagulopathy.急性创伤性出血和创伤诱导性凝血病的止血控制策略。
Expert Rev Hematol. 2018 Dec;11(12):987-995. doi: 10.1080/17474086.2018.1548929. Epub 2018 Nov 27.
3
Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): study protocol for a pilot randomized controlled trial.
创伤相关严重出血的院前评估(phTASH)——对2015年至2021年创伤登记DGU数据的分析
Scand J Trauma Resusc Emerg Med. 2025 Jul 1;33(1):115. doi: 10.1186/s13049-025-01404-4.
4
Inhospital coagulation management and fluid replacement therapy in patients with multiple and/or severe injuries - a systematic review and clinical practice guideline update.多发伤和/或重伤患者的院内凝血管理及液体替代治疗——系统评价与临床实践指南更新
Eur J Trauma Emerg Surg. 2025 Jun 27;51(1):240. doi: 10.1007/s00068-025-02919-2.
5
Trauma-Induced Coagulopathy: A Review of Specific Molecular Mechanisms.创伤性凝血病:特定分子机制综述
Diagnostics (Basel). 2025 Jun 5;15(11):1435. doi: 10.3390/diagnostics15111435.
6
Association between fibrinogen levels and prognosis in critically bleeding patients: exploration of the optimal therapeutic threshold.严重出血患者纤维蛋白原水平与预后的关系:最佳治疗阈值的探索
Eur J Trauma Emerg Surg. 2025 May 23;51(1):219. doi: 10.1007/s00068-025-02886-8.
7
Applications of Hydrogels in Emergency Therapy.水凝胶在急救治疗中的应用。
Gels. 2025 Mar 23;11(4):234. doi: 10.3390/gels11040234.
8
The obstetrician attached to the obstetric emergency.负责产科急诊的产科医生。
Colomb Med (Cali). 2024 Sep 25;55(3):e3006574. doi: 10.25100/cm.v55i3.6574. eCollection 2024 Jul-Sep.
9
Utility of point of care viscoelastic haemostatic assays for trauma patients in the emergency department.即时粘弹性止血检测在急诊科创伤患者中的应用价值。
Scand J Trauma Resusc Emerg Med. 2025 Apr 24;33(1):68. doi: 10.1186/s13049-025-01388-1.
10
Rethinking vasopressor use in the trauma bay: a shifting perspective.重新审视创伤急救室血管加压药的使用:视角的转变
Trauma Surg Acute Care Open. 2025 Apr 14;10(Suppl 1):e001788. doi: 10.1136/tsaco-2025-001788. eCollection 2025.
儿童创伤性损伤中氨甲环酸评估的临床试验(TIC-TOC):一项试点随机对照试验的研究方案
Trials. 2018 Oct 30;19(1):593. doi: 10.1186/s13063-018-2974-z.
4
Ongoing redistribution of dabigatran necessitates repetitive application of idarucizumab.达比加群的持续再分布需要重复使用艾达司珠单抗。
Br J Anaesth. 2018 Aug;121(2):505-508. doi: 10.1016/j.bja.2018.04.025. Epub 2018 Jun 12.
5
New Viewpoint in Exaggerated Increase of PtiO With Normobaric Hyperoxygenation and Reasons to Limit Oxygen Use in Neurotrauma Patients.常压高氧时PtiO异常升高的新观点及限制神经创伤患者使用氧气的原因
Front Med (Lausanne). 2018 May 22;5:119. doi: 10.3389/fmed.2018.00119. eCollection 2018.
6
Data-driven Development of ROTEM and TEG Algorithms for the Management of Trauma Hemorrhage: A Prospective Observational Multicenter Study.基于数据的 ROTEM 和 TEG 算法在创伤性出血管理中的开发:一项前瞻性观察性多中心研究。
Ann Surg. 2019 Dec;270(6):1178-1185. doi: 10.1097/SLA.0000000000002825.
7
Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.急性危重病患者接受宽松与保守氧疗的死亡率和发病率(IOTA):系统评价和荟萃分析。
Lancet. 2018 Apr 28;391(10131):1693-1705. doi: 10.1016/S0140-6736(18)30479-3. Epub 2018 Apr 26.
8
Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients.急性创伤患者低纤维蛋白原血症的早期预测因素
J Emerg Trauma Shock. 2018 Jan-Mar;11(1):38-41. doi: 10.4103/JETS.JETS_37_17.
9
Platelet transfusion increases risk for acute respiratory distress syndrome in non-massively transfused blunt trauma patients.血小板输注会增加非大量输血钝性创伤患者急性呼吸窘迫综合征的风险。
Eur J Trauma Emerg Surg. 2019 Aug;45(4):671-679. doi: 10.1007/s00068-018-0953-4. Epub 2018 Apr 7.
10
Manchester Arena bombing: lessons learnt from a mass casualty incident.曼彻斯特竞技场爆炸案:重大人员伤亡事件的教训。
BMJ Mil Health. 2020 Apr;166(2):72-75. doi: 10.1136/jramc-2018-000930. Epub 2018 Apr 6.